HEPION PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Income Taxes
HEPION PHARMACEUTICALS, INC. (HEPA) reported Increase (Decrease) in Deferred Income Taxes of $409.02 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2025-04-08
- HEPION PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for fiscal 2023 was $409.02K.
- HEPION PHARMACEUTICALS, INC. increase (decrease) in deferred income taxes for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|
| 2023-12-31 | $409.02K 10-K · filed 2025-04-08 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |
| 2020-06-30 | -$30.43K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |